Hypomethylation of DNA: a possible nongenotoxic mechanism underlying the role of cell proliferation in carcinogenesis
- PMID: 8013405
- PMCID: PMC1519424
- DOI: 10.1289/ehp.93101s5169
Hypomethylation of DNA: a possible nongenotoxic mechanism underlying the role of cell proliferation in carcinogenesis
Abstract
DNA methylation (i.e., the 5-methylcytosin content of DNA) plays a role in the regulation of gene activity. There is a persuasive body of evidence indicating that differential methylation of DNA (i.e., 5-methylcytosine versus cytosine) is a determinant of chromatin structure and that the methyl group provides a chemical signal that is recognized by trans-acting factors that regulate transcription. Hypomethylation (i.e., low levels of DNA 5-methylcytosine) of a gene is necessary but not sufficient for its expression, and, therefore, a hypomethylated gene can be considered to possess an increased potential for expression as compared to a hypermethylated gene. Cell proliferation is a fundamental component of carcinogenesis. It plays a key role in expanding clones of initiated cells and, in addition, cell replication may contribute to carcinogenesis by facilitating mutagenesis. This can occur either by causing the fixation of promutagenic DNA-damage before repair or as a consequence of a "normal" error occurring during DNA replication. During periods of cell proliferation the established pattern of DNA methylation is maintained by the action of a maintenance methylase following DNA replication. Changes in the methylation status of a gene provide a mechanism by which its potential for expression can be altered in an epigenetic heritable manner, and it is expected that modifications in DNA methylation would result from threshold-exhibiting events.
Similar articles
-
Hypomethylation of DNA: a possible epigenetic mechanism involved in tumor promotion.Prog Clin Biol Res. 1995;391:81-101. Prog Clin Biol Res. 1995. PMID: 8532739 Review.
-
DNA methylation and the association between genetic and epigenetic changes: relation to carcinogenesis.Mutat Res. 1997 Apr 14;375(1):1-8. doi: 10.1016/s0027-5107(97)00003-1. Mutat Res. 1997. PMID: 9129674 Review.
-
Hypomethylation of DNA: a nongenotoxic mechanism involved in tumor promotion.Toxicol Lett. 1995 Dec;82-83:663-72. doi: 10.1016/0378-4274(95)03512-5. Toxicol Lett. 1995. PMID: 8597125
-
DNA hypomethylation during liver cell proliferation induced by a single dose of lead nitrate.Boll Soc Ital Biol Sper. 1991 Dec;67(12):993-7. Boll Soc Ital Biol Sper. 1991. PMID: 1840801
-
DNA methylation and polyamines in embryonic development and cancer.Int J Dev Biol. 1995 Oct;39(5):737-57. Int J Dev Biol. 1995. PMID: 8645558 Review.
Cited by
-
Colorectal tumor molecular phenotype and miRNA: expression profiles and prognosis.Mod Pathol. 2016 Aug;29(8):915-27. doi: 10.1038/modpathol.2016.73. Epub 2016 May 20. Mod Pathol. 2016. PMID: 27198570 Free PMC article.
-
Promoter hypomethylation as potential confounder of Ras gene overexpression and their clinical significance in subsets of urothelial carcinoma of bladder.Mol Biol Rep. 2021 Mar;48(3):2183-2199. doi: 10.1007/s11033-021-06227-x. Epub 2021 Feb 23. Mol Biol Rep. 2021. PMID: 33620658
-
Anomalous nonidentity between Salmonella genotoxicants and rodent carcinogens: nongenotoxic carcinogens and genotoxic noncarcinogens.Environ Health Perspect. 1996 Jan;104(1):40-6. doi: 10.1289/ehp.9610440. Environ Health Perspect. 1996. PMID: 8834860 Free PMC article. Review.
-
Cell proliferation and chemical carcinogenesis: symposium overview.Environ Health Perspect. 1993 Dec;101 Suppl 5(Suppl 5):3-7. doi: 10.1289/ehp.93101s53. Environ Health Perspect. 1993. PMID: 7912189 Free PMC article. Review.
-
DNA Methylation and Flavonoids in Genitourinary Cancers.Curr Pharmacol Rep. 2015 Apr 1;1(2):112-120. doi: 10.1007/s40495-014-0004-8. Curr Pharmacol Rep. 2015. PMID: 26005633 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources